Clinical characteristics of miliary pulmonary metastases in non‐small cell lung cancer

Background The prognosis of miliary pulmonary metastases (MPM), which are characterized as randomly disseminated, innumerable, and small metastatic nodules, has been considered as being poor. The purpose of this study was to evaluate the clinical characteristics and survival of MPM in patients with...

Full description

Saved in:
Bibliographic Details
Published in:Thoracic cancer 2023-08, Vol.14 (22), p.2168-2176
Main Authors: Choi, Hanmil, Im, Yunjoo, Jeong, Byeong‐Ho, Lee, Kyungjong, Kim, Hojoong, Um, Sang‐Won
Format: Article
Language:English
Subjects:
Carcinoma, Non-Small-Cell Lung - pathology
Cloning
EGFR mutation
ErbB Receptors - genetics
Females
Histology
Humans
Kinases
Lung cancer
Lung Neoplasms - pathology
Medical imaging
Medical records
Metastasis
miliary pulmonary metastases
Mutation
non‐small cell lung cancer
Original
overall survival
Prognosis
Protein Kinase Inhibitors
Retrospective Studies
Tomography
Variables
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background The prognosis of miliary pulmonary metastases (MPM), which are characterized as randomly disseminated, innumerable, and small metastatic nodules, has been considered as being poor. The purpose of this study was to evaluate the clinical characteristics and survival of MPM in patients with non‐small cell lung cancer (NSCLC). Methods This retrospective study included NSCLC patients with MPM and nonmiliary pulmonary metastases (NMPM) detected during staging evaluation between 2000 and 2020. MPM was defined as >50 bilaterally distributed metastatic pulmonary nodules (
ISSN:1759-7706
1759-7714
DOI:10.1111/1759-7714.15003